WOUND MANAGEMENT TECHNOLOGIES, INC. 5
5 · WOUND MANAGEMENT TECHNOLOGIES, INC. · Filed Feb 14, 2014
Insider Transaction Report
Form 5
Lutz Robert Jr.
DirectorPresident and CEO
Transactions
- Award
Series D Preferred Stock
2013-02-15+6,000→ 6,000 total→ Common Stock (6,000,000 underlying) - Other
Warrant
2013-02-15+3,000,000→ 0 totalExercise: $0.15From: 2012-08-17Exp: 2017-03-31→ Common Stock (3,000,000 underlying) - Purchase
Series C Preferred Stock
2013-11-12$70.00/sh+3,257$227,990→ 3,257 total→ Common Stock (3,257,000 underlying)
Footnotes (2)
- [F1]In conjunction with his agreement to the cancellation of warrants for the purchase of 3,000 shares of the issuer's common stock, the reporting person received,pursuant to a fully vested grant approved by the issuer's board of directors, 6,000 shares of the issuer's Series D Preferred Stock.Each share of Series D Preferred Stock will automatically be converted into 1,000 shares of the issuer's common stock upon effectiveness of an increase in the authorized number of shares of common stock from 100,000,000 to 250,000,000.
- [F2]Each share of Series C Preferred Stock is convertible into 1,000 shares of the issuer's common stock, subject to the effectiveness of an increase in the authorized number of shares of common stock from 100,000,000 to 250,000,000.